Kraig Biocraft Laboratories, Inc.
- Jurisdiction
United States - ISIN
US50075W1045 (KBLB )- Sectors
Scores
- Fair value (Benjamin Graham formula)
- N/A
- Financial strength (Piotroski F-Value)
-
3
/ 9
- Fundamental strength relative to industry (Mohanram G-Value)
-
4
/ 7
Profile
Kraig Biocraft Laboratories, Inc. engages in developing protein-based fibers using recombinant DNA technology for commercial applications in the technical textile and specialty fiber industries in the United States. Read full profile
Fundamentals
- Net revenue
€22.96K - Gross margin
50.0% - EBIT
-€2.01M - EBIT margin
-8,758.7% - Net income
-€2.23M - Net margin
-9,699.1%
Statement period: - (published )
Stock price
Dividends
No dividend payouts
Analyst ratings
No analyst ratings available
Insider Transactions
No insider transactions in the last 90 days. View older insider transactions